Lead-DBS v3.0: Mapping deep brain stimulation effects to local anatomy and global networks.

Humans Deep Brain Stimulation / methods Parkinson Disease / therapy Retrospective Studies Subthalamic Nucleus Brain / diagnostic imaging Magnetic Resonance Imaging / methods
Deep brain stimulation Functional connectivity Group-level Imaging Structural connectivity

Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
03 2023
Historique:
received: 19 07 2022
revised: 22 12 2022
accepted: 03 01 2023
pubmed: 8 1 2023
medline: 11 2 2023
entrez: 7 1 2023
Statut: ppublish

Résumé

Following its introduction in 2014 and with support of a broad international community, the open-source toolbox Lead-DBS has evolved into a comprehensive neuroimaging platform dedicated to localizing, reconstructing, and visualizing electrodes implanted in the human brain, in the context of deep brain stimulation (DBS) and epilepsy monitoring. Expanding clinical indications for DBS, increasing availability of related research tools, and a growing community of clinician-scientist researchers, however, have led to an ongoing need to maintain, update, and standardize the codebase of Lead-DBS. Major development efforts of the platform in recent years have now yielded an end-to-end solution for DBS-based neuroimaging analysis allowing comprehensive image preprocessing, lead localization, stimulation volume modeling, and statistical analysis within a single tool. The aim of the present manuscript is to introduce fundamental additions to the Lead-DBS pipeline including a deformation warpfield editor and novel algorithms for electrode localization. Furthermore, we introduce a total of three comprehensive tools to map DBS effects to local, tract- and brain network-levels. These updates are demonstrated using a single patient example (for subject-level analysis), as well as a retrospective cohort of 51 Parkinson's disease patients who underwent DBS of the subthalamic nucleus (for group-level analysis). Their applicability is further demonstrated by comparing the various methodological choices and the amount of explained variance in clinical outcomes across analysis streams. Finally, based on an increasing need to standardize folder and file naming specifications across research groups in neuroscience, we introduce the brain imaging data structure (BIDS) derivative standard for Lead-DBS. Thus, this multi-institutional collaborative effort represents an important stage in the evolution of a comprehensive, open-source pipeline for DBS imaging and connectomics.

Identifiants

DOI: 10.1016/j.neuroimage.2023.119862 PMID: 36610682 PMC: PMC10144063
pubmed: 36610682
pii: S1053-8119(23)00011-3
doi: 10.1016/j.neuroimage.2023.119862
pmc: PMC10144063
mid: NIHMS1890284
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

119862

Subventions

Organisme : NINDS NIH HHS
ID : R21 NS123813
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG069086
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH130666
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH113929
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH126271
Pays : United States

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Références

Mov Disord. 2020 Feb;35(2):337-343
pubmed: 31758821
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):E4367-75
pubmed: 25267639
AJNR Am J Neuroradiol. 2020 Sep;41(9):1558-1568
pubmed: 32816768
Biomed Eng Online. 2018 Mar 27;17(1):37
pubmed: 29580236
IEEE Trans Biomed Eng. 2015 Feb;62(2):664-672
pubmed: 25350910
Stereotact Funct Neurosurg. 2018;96(5):335-341
pubmed: 30481772
Curr Biol. 2021 Oct 25;31(20):4436-4448.e5
pubmed: 34437842
Ann Neurol. 2020 Jun;87(6):962-975
pubmed: 32239535
Ann Neurol. 2018 Jul;84(1):153-157
pubmed: 30014594
Sci Data. 2018 Jun 19;5:180110
pubmed: 29917016
Brain. 2022 Dec 19;145(12):4385-4397
pubmed: 35026844
Neuroimage. 2019 Jan 1;184:586-598
pubmed: 30267856
PLoS Comput Biol. 2020 Jul 6;16(7):e1008023
pubmed: 32628719
Elife. 2022 May 20;11:
pubmed: 35594135
Mov Disord. 2021 Feb;36(2):380-388
pubmed: 33002233
Ann Neurol. 2017 Jul;82(1):67-78
pubmed: 28586141
Neuroimage. 2017 Sep;158:332-345
pubmed: 28711737
Magn Reson Imaging. 2012 Nov;30(9):1323-41
pubmed: 22770690
Neuroimage. 2014 Nov 15;102 Pt 1:142-51
pubmed: 24099851
Brain. 2018 Aug 1;141(8):2445-2456
pubmed: 29982424
Brain. 2019 Oct 1;142(10):3086-3098
pubmed: 31377766
Brain Commun. 2021 Mar 10;3(2):fcab027
pubmed: 33870190
Brain. 2021 Oct 22;144(9):2837-2851
pubmed: 33905474
Hum Brain Mapp. 2016 Jan;37(1):422-33
pubmed: 26523416
Nat Biotechnol. 2021 Sep;39(9):1078-1085
pubmed: 33941932
J Neurosci Methods. 2018 Oct 1;308:366-376
pubmed: 30201271
J Comput Neurosci. 2009 Feb;26(1):109-18
pubmed: 18553218
Clin Neurophysiol. 2005 Oct;116(10):2490-500
pubmed: 16125463
Neuroimage. 2018 Apr 15;170:271-282
pubmed: 28536045
Ann Neurol. 2022 May;91(5):602-612
pubmed: 35150172
Neuroimage. 2021 Jan 1;224:117307
pubmed: 32861787
Neurosci Res. 2002 Jun;43(2):111-7
pubmed: 12067746
Biol Psychiatry. 2019 May 1;85(9):735-743
pubmed: 30777287
Nat Methods. 2019 Jan;16(1):111-116
pubmed: 30532080
Ann Neurol. 2020 Dec;88(6):1178-1193
pubmed: 32951262
Neuroimage. 2020 Oct 1;219:117018
pubmed: 32505698
Hum Brain Mapp. 2019 Feb 15;40(3):889-903
pubmed: 30311317
J Neural Eng. 2019 Oct 29;16(6):066024
pubmed: 31426036
Neuroimage. 2013 Oct 15;80:105-24
pubmed: 23668970
Ann Neurol. 2019 Oct;86(4):527-538
pubmed: 31376171
Nat Commun. 2020 Jul 3;11(1):3364
pubmed: 32620886
Ann Neurol. 2022 May;91(5):613-628
pubmed: 35165921
Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:5212-5216
pubmed: 31947033
Sci Data. 2016 Jun 21;3:160044
pubmed: 27326542
Proc Natl Acad Sci U S A. 2022 Apr 5;119(14):e2114985119
pubmed: 35357970
Neuroimage Clin. 2020;27:102271
pubmed: 32446242
Brain. 2022 Mar 29;145(1):251-262
pubmed: 34453827
Brain. 2020 Jul 1;143(7):2235-2254
pubmed: 32568370
Brain. 2019 May 1;142(5):1386-1398
pubmed: 30851091
Sci Data. 2019 Jun 25;6(1):102
pubmed: 31239438
Neuroimage. 2016 Jan 1;124(Pt A):310-322
pubmed: 26327244
Neuroimage. 2011 Feb 1;54(3):2096-104
pubmed: 20974269
Hum Brain Mapp. 2021 Sep;42(13):4399-4421
pubmed: 34101297
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
Nat Commun. 2021 May 24;12(1):3043
pubmed: 34031407
Curr Opin Neurol. 2019 Aug;32(4):511-520
pubmed: 30844863
Brain. 2019 Oct 1;142(10):3129-3143
pubmed: 31412106
PLoS One. 2017 Apr 25;12(4):e0176132
pubmed: 28441410
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):601-606
pubmed: 29255017
Sci Data. 2019 Oct 30;6(1):244
pubmed: 31666530
Brain. 2020 Aug 1;143(8):2607-2623
pubmed: 32653920
Brain. 2022 May 24;145(4):1410-1421
pubmed: 35037938
Science. 2013 Jun 21;340(6139):1472-5
pubmed: 23788795
Neuroimage Clin. 2018;20:868-874
pubmed: 30282063
Biol Psychiatry. 2021 Nov 15;90(10):701-713
pubmed: 34134839
Brain. 2022 May 24;145(4):1338-1353
pubmed: 35025994
Brain. 2018 Sep 1;141(9):2655-2669
pubmed: 30084974
Ann Neurol. 2014 Aug;76(2):279-95
pubmed: 24953991
Neuroimage. 2020 Nov 1;221:117180
pubmed: 32702488
Hum Brain Mapp. 2017 Jul;38(7):3377-3390
pubmed: 28390148
Neuroimage. 2011 Feb 1;54(3):2033-44
pubmed: 20851191
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9566-9576
pubmed: 32284420
Biol Psychiatry. 2018 Jul 1;84(1):28-37
pubmed: 29274805
Ann Neurol. 2021 Mar;89(3):426-443
pubmed: 33252146
Neuroimage. 2018 May 15;172:263-277
pubmed: 29331449
Stereotact Funct Neurosurg. 2019;97(5-6):369-380
pubmed: 31865344
Front Neurol. 2021 May 14;12:669690
pubmed: 34054710
Neuroimage Clin. 2017 Oct 06;17:80-89
pubmed: 29062684
Sci Data. 2019 Jun 25;6(1):103
pubmed: 31239435
Ann Neurol. 2020 Nov;88(5):956-969
pubmed: 32827225
Sci Data. 2020 Sep 15;7(1):305
pubmed: 32934244
Neuroimage. 2020 Dec;223:117330
pubmed: 32890746
Neuroimage. 2015 Feb 15;107:127-135
pubmed: 25498389
Brain. 2023 Apr 19;146(4):1672-1685
pubmed: 36181425
Acta Neurochir (Wien). 2013 Sep;155(9):1647-54; discussion 1654
pubmed: 23775325
J Neurophysiol. 2002 Feb;87(2):995-1006
pubmed: 11826063
J Neurophysiol. 2011 Sep;106(3):1125-65
pubmed: 21653723
Acta Neurochir Suppl. 2007;97(Pt 2):561-7
pubmed: 17691348
Alzheimers Dement. 2021 May;17(5):777-787
pubmed: 33480187
Elife. 2022 May 27;11:
pubmed: 35621994
Neuroimage. 2019 Jan 1;184:293-316
pubmed: 30179717
Neuroimage. 2017 Apr 15;150:395-404
pubmed: 28163141
Neuromodulation. 2022 Aug;25(6):877-887
pubmed: 33476474
Nat Neurosci. 2016 Aug 26;19(9):1175-87
pubmed: 27571196
Neuroimage Clin. 2022;34:102971
pubmed: 35231852
Brain Sci. 2021 Oct 31;11(11):
pubmed: 34827449

Auteurs

Clemens Neudorfer (C)

Brain Modulation Lab, Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, 02114, USA; Harvard Medical School, Boston, MA, 02114, USA; Center for Brain Circuit Therapeutics Department of Neurology Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA; Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Electronic address: clemens.neudorfer@gmail.com.

Konstantin Butenko (K)

Center for Brain Circuit Therapeutics Department of Neurology Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.

Simon Oxenford (S)

Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Nanditha Rajamani (N)

Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Johannes Achtzehn (J)

Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Lukas Goede (L)

Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Berlin, Germany.

Barbara Hollunder (B)

Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Einstein Center for Neurosciences Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Berlin, Germany.

Ana Sofía Ríos (AS)

Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Lauren Hart (L)

Center for Brain Circuit Therapeutics Department of Neurology Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.

Jordy Tasserie (J)

Division of Neurosurgery, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON M5T 2S8, Canada.

Kavisha B Fernando (KB)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Australia.

T A Khoa Nguyen (TAK)

Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; ARTORG Center for Biomedical Engineering Research, University of Bern, Bern, Switzerland.

Bassam Al-Fatly (B)

Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Matteo Vissani (M)

Brain Modulation Lab, Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, 02114, USA; Harvard Medical School, Boston, MA, 02114, USA.

Michael Fox (M)

Center for Brain Circuit Therapeutics Department of Neurology Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.

R Mark Richardson (RM)

Brain Modulation Lab, Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, 02114, USA; Harvard Medical School, Boston, MA, 02114, USA; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, United States.

Ursula van Rienen (U)

Institute of General Electrical Engineering, University of Rostock, Rostock, Germany; Department Life, Light & Matter, University of Rostock, Rostock, Germany; Department Ageing of Individuals and Society, University of Rostock, Rostock, Germany.

Andrea A Kühn (AA)

Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Andreas D Husch (AD)

University of Luxembourg, Luxembourg Centre for Systems Biomedicine, 4362, Esch-sur-Alzette, Luxembourg.

Enrico Opri (E)

Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.

Till Dembek (T)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Ningfei Li (N)

Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Electronic address: ningfei.li@charite.de.

Andreas Horn (A)

Harvard Medical School, Boston, MA, 02114, USA; Center for Brain Circuit Therapeutics Department of Neurology Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA; Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Electronic address: ahorn1@bwh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Lead-DBS v3.0: Mapping deep brain stimulation...
questionsmedicales.fr › Procédures de chirurgie opératoire › Stimulation cérébrale profonde › Lead-DBS v3.0: Mapping deep brain stimulation...
questionsmedicales.fr › Maladies du système nerveux › Maladies neurodégénératives › Maladie de Parkinson › Lead-DBS v3.0: Mapping deep brain stimulation...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Lead-DBS v3.0: Mapping deep brain stimulation...
questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Prosencéphale › Diencéphale › Subthalamus › Noyau subthalamique › Lead-DBS v3.0: Mapping deep brain stimulation...
questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Lead-DBS v3.0: Mapping deep brain stimulation...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Imagerie par résonance magnétique › Lead-DBS v3.0: Mapping deep brain stimulation...